[Protective effects of fosfomycin against experimentally induced mast cell degranulation].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000242:Cyclic AMP / Q000378:metabolism; D006152:Cyclic GMP / Q000378:metabolism; D005578:Fosfomycin / Q000494:pharmacology*; D006636:Histamine Release / Q000187:drug effects*; D008297:Male; D008407:Mast Cells / Q000187:drug effects* / Q000378:metabolism; D051381:Rats; D003189:p-Methoxy-N-methylphenethylamine / Q000037:antagonists & inhibitors
D000900:Anti-Bacterial Agents; D005578:Fosfomycin; D003189:p-Methoxy-N-methylphenethylamine; D000242:Cyclic AMP; D006152:Cyclic GMP
Effetto protettivo della fosfomicina sulla degranulazione mastocitaria sperimentalmente indotta.